Modafinil: the smart drug with a reputation far less epic than its effects
Daily users describe tunnel vision, anxiety and a state that is neither stimulated nor rested, according to a forum discussion.
English · Original discussion in Spanish · Published
Modafinil doesn't make you smarter, it just keeps you awake
Modafinil has earned a fruta as the smart drug in the corridors of power. The reality described by those who have tried it is less epic: it keeps you awake, it doesn't make you brilliant. And when taken many days in a row, the body pays the price. The result is an uncomfortable state that is neither focus nor rest.
The promise is appealing: perform around the clock, stay alert without the toll of coffee or the rollercoaster of cocaine. The official narrative presents it as a productivity tool. The experience of those who have used it daily points to something else.
What are modafinil's side effects?
The catalogue of adverse effects discussed in these conversations includes **tunnel vision** (focusing so hard on one task that you lose the bigger picture), **overconfidence** (believing decisions are brilliant when they are standard) and psychiatric disorders ranging from anxiety to aggression, with psychosis at the extreme. It is not a multivitamin.
Some who have tried it describe a whole night *grinding their jaw* like a cocaine user, but without having taken anything illegal and without ending up vomiting in public restrooms. The problem comes with repetition: **many days in a row** leave you in a strange state, neither stimulated nor rested. Body and mind ask for a break and don't get one.
The suggested solution is to take breaks, alternate with other substances or space out doses. Nothing that solves the underlying issue: modafinil is artificial and doesn't fit well with the body's natural rhythm.
Modafinil vs methylphenidate: what experience says
Modafinil has a better-known pharmacological cousin, **extended-release methylphenidate**, prescribed for ADHD. The accounts of those who have tried both are revealing. In one case, modafinil was barely noticeable and caused a facial tic of jaw movement. Methylphenidate, at a dose of **54 mg**, worked well the first days with a noticeable high; when lowered to **32 mg**, the effect moderated.
The problem came on the off days: a feeling of mental, physical and emotional collapse. Many prefer a worse but stable state over the lows of withdrawal. The conclusion drawn is that these pills are not free: the energy loan is repaid with interest.
The little smart pill and the Silicon Valley story
In power circles, people talk about someone who seems *tireless* or *switched on* around the clock. That is modafinil's fame: the smart drug, the life tonic of an elite that cannot afford to sleep. The reality is more prosaic. Most of those who take it without medical supervision are not geniuses: they are people with too much work and too little rest.
Recreational or professional use without medical oversight is dangerous. There is no chemical shortcut to alertness. And the price is paid in anxiety, exhaustion and dependence.
Some compare these substances with older ones, such as **sydnofen** and **sydnocarb**, which were presented as safer than amphetamine and promised a clearer face and a slimmer body. Over time, the side effects took their toll, especially on the **thyroid**.
The conversation drifts toward amphetamine, permitted in wartime under control and in limited doses, and used as an antidepressant in the **1980s** until it was found that depression worsened after treatment. **Strychnine** is also mentioned, a stimulant used in the same decade whose overdose is lethal. The 20th century was prolific in experiments on human guinea pigs.
On consumption by political sectors, the conversation offers an ironic take: the left would be fonder of pills since their adolescence in parks, while the far right would prefer coke with ham and sparkling wine. It is a caricature, not a fact.
Nicotine and other alternatives to modafinil
Against modafinil, some mention **nicotine pouches** as a more manageable stimulant: short-lived, they allow good sleep and taste better. Nicotine is a toxin and a plant insecticide, and it feels like it the first few times. The trick would be to alternate days between one and the other.
The unavoidable conclusion is that there is no stimulant without a toll. Modafinil is no exception. The question left hanging is how many of those who boast of being tireless are simply in debt to their own body.
Modafinil has earned a fruta as the smart drug in the corridors of power. The reality described by those who have tried it is less epic: it keeps you awake, it doesn't make you brilliant. And when taken many days in a row, the body pays the price. The result is an uncomfortable state that is neither focus nor rest.
The promise is appealing: perform around the clock, stay alert without the toll of coffee or the rollercoaster of cocaine. The official narrative presents it as a productivity tool. The experience of those who have used it daily points to something else.
What are modafinil's side effects?
The catalogue of adverse effects discussed in these conversations includes **tunnel vision** (focusing so hard on one task that you lose the bigger picture), **overconfidence** (believing decisions are brilliant when they are standard) and psychiatric disorders ranging from anxiety to aggression, with psychosis at the extreme. It is not a multivitamin.
Some who have tried it describe a whole night *grinding their jaw* like a cocaine user, but without having taken anything illegal and without ending up vomiting in public restrooms. The problem comes with repetition: **many days in a row** leave you in a strange state, neither stimulated nor rested. Body and mind ask for a break and don't get one.
The suggested solution is to take breaks, alternate with other substances or space out doses. Nothing that solves the underlying issue: modafinil is artificial and doesn't fit well with the body's natural rhythm.
Modafinil vs methylphenidate: what experience says
Modafinil has a better-known pharmacological cousin, **extended-release methylphenidate**, prescribed for ADHD. The accounts of those who have tried both are revealing. In one case, modafinil was barely noticeable and caused a facial tic of jaw movement. Methylphenidate, at a dose of **54 mg**, worked well the first days with a noticeable high; when lowered to **32 mg**, the effect moderated.
The problem came on the off days: a feeling of mental, physical and emotional collapse. Many prefer a worse but stable state over the lows of withdrawal. The conclusion drawn is that these pills are not free: the energy loan is repaid with interest.
The little smart pill and the Silicon Valley story
In power circles, people talk about someone who seems *tireless* or *switched on* around the clock. That is modafinil's fame: the smart drug, the life tonic of an elite that cannot afford to sleep. The reality is more prosaic. Most of those who take it without medical supervision are not geniuses: they are people with too much work and too little rest.
Recreational or professional use without medical oversight is dangerous. There is no chemical shortcut to alertness. And the price is paid in anxiety, exhaustion and dependence.
Some compare these substances with older ones, such as **sydnofen** and **sydnocarb**, which were presented as safer than amphetamine and promised a clearer face and a slimmer body. Over time, the side effects took their toll, especially on the **thyroid**.
The conversation drifts toward amphetamine, permitted in wartime under control and in limited doses, and used as an antidepressant in the **1980s** until it was found that depression worsened after treatment. **Strychnine** is also mentioned, a stimulant used in the same decade whose overdose is lethal. The 20th century was prolific in experiments on human guinea pigs.
On consumption by political sectors, the conversation offers an ironic take: the left would be fonder of pills since their adolescence in parks, while the far right would prefer coke with ham and sparkling wine. It is a caricature, not a fact.
Nicotine and other alternatives to modafinil
Against modafinil, some mention **nicotine pouches** as a more manageable stimulant: short-lived, they allow good sleep and taste better. Nicotine is a toxin and a plant insecticide, and it feels like it the first few times. The trick would be to alternate days between one and the other.
The unavoidable conclusion is that there is no stimulant without a toll. Modafinil is no exception. The question left hanging is how many of those who boast of being tireless are simply in debt to their own body.
Also available in: Deutsch
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (15 replies).
More summaries
-
Alcàsser Case: AI Bias Test with Three Models
A nine-day experiment queries ChatGPT-4o mini on the Alcàsser case: identical prompts yield three distinct AI responses, revealing significant bias.
-
Spain's Mandela effects: when memory gets it wrong
Mayra Gómez Kemp, Rocío Jurado, Tejero or Rafa Guerrero's famous line: Mandela effect cases in Spain that call collective memory into question.
-
Organic Portals: The Theory That Says 80% Have No Soul
Between 50% and 85% of the population are soulless 'organic portals'. The theory, its esoteric sources, and why it fascinates in the digital age.
-
Trump, Epstein and the cyberattack that's supposedly coming
The Trump-Epstein relationship is at the center of a theory predicting cyberattacks by "rogue AI" to cover up upcoming arrests. There is no evidence of any such plan.
-
Eyes Wide Shut: the hidden symbolism behind Kubrick's final film
A 17-chapter series reads Eyes Wide Shut as an Orphic initiation story: over 800 pages of symbolic analysis of Stanley Kubrick's last film.
-
The May 8, 2040 end-of-the-world date that doesn't add up
The claim that the world will end on May 8, 2040 comes from a round figure of ten thousand days, not from The Limits to Growth, the report cited as evidence.